DF

Daniel R. Frank

Director at Glytec

Mr. Frank started his investment career in 1979 as an analyst with Fidelity Management and Research (Fidelity Investments). In 1981, he became an assistant to Peter Lynch on the Fidelity Magellan Fund and in 1982, he formally launched his own fund, Fidelity Special Situations/Strategic Opportunities Fund, which grew to over $800 million. For a decade, Mr. Frank was a Managing Director at Cerberus Capital Management, responsible for healthcare related investments in both the public and private markets, from start-ups to established businesses in need of growth capital. In this role, he served as lead investor, co-investor, and in various roles on the Board of Directors of the respective investments. The areas of focus encompassed diagnostics, specialty pharmaceuticals and medical devices.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Glytec

1 followers

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home.


Industries

Employees

51-200

Links